双方式溶解微针与纳米颗粒涂层和封装,用于扩展双药物输送
Mingshan Li1, Akmal H B Sabri1,2, Nuoya Qin1
1School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
Small (Weinheim an der Bergstrasse, Germany)
|May 26, 2025
概括
这项研究引入了双模溶解微针 (DMN) 用于持续同时输送二二甲和甲二甲纳米颗粒,通过单个贴片为骨关节炎提供了改进的治疗方法.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 微针 (MN) 平台面临着由于有限的容量和持续释放要求,在联合提供多种药物方面面临挑战.
- 骨关节炎的治疗需要有效的,持续的抗炎药物,如迪克洛芬雅克 (DCF) 和德克萨米 (DSP).
研究的目的:
- 开发和评估双模涂层溶解微针 (DMN) 贴片,用于扩展二二甲和甲纳米颗粒的联合输送.
- 评估用于骨关节炎治疗的双药装载DMN的通过皮肤透,释放动力学和体内药理动力学.
主要方法:
- 用DCF纳米粒子在尖端和DSP-PLGA纳米悬浮作为涂层制造DMN.
- 使用新生猪皮肤进行ex vivo皮肤透研究,以评估DMN的疗效.
- 在老鼠体内进行的药理动力学研究,以确定药物的血水平,生物可用性和组织分布.
主要成果:
- DMN实现了>90%的透到角层,有效地提供DCF和DSP.
- 在体内研究显示持续DCF血水平72小时 (13.0小时半衰期,80.3%的生物可用性) 和双相DSP释放达到24-30小时 (63.9%的生物可用性) 的峰值.
- 高度的药物在皮肤和脚组织中维持了72小时,表明局部治疗效果持续了很长时间.
结论:
- 双通道DMN提供了一个高负载,持续释放的平台,用于微创的双药疗法.
- 这种方法优化了骨关节炎的治疗,通过一个对患者友好的,单片补丁输送系统来提高患者的遵守性.
- 开发的DMN技术显示出改善局部药物输送和治疗结果的巨大潜力.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.1K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.1K
Drug Delivery: Overview
431
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
431


